Frank Pasqualone, SVP, Chief Comm Operations Officer at Theravance Biopharma, Inc. (TBPH), bought 4,000 shares at $26.34 ($105K) on 2017-08-21, disclosed to the SEC on 2017-08-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.